UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.696

Sortiert nach

2D/3D cryo x-ray fluorescence imaging at the bionanoprobe at the advanced photon source

AIP Conference Proceedings, 2016, Vol.1696 (1)

2016

Volltextzugriff (PDF)

3D-VUPID: 3D Visual Urban Planning Integrated Data

Computational Science and Its Applications – ICCSA 2013, p.17-32

Volltextzugriff (PDF)

901: Guidelines for dosimetric tracking using reference points in radiation oncology information systems

Radiotherapy and oncology, 2024-05, Vol.194, p.S4198-S4200

2024

Volltextzugriff (PDF)

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma

Nature communications, 2022-03, Vol.13 (1), p.1363-1363, Article 1363

2022

Volltextzugriff (PDF)

Ability To Fine-Tune the Electronic Properties and Open-Circuit Voltage of Phenoxy-Boron Subphthalocyanines through Meta-Fluorination of the Axial Substituent

Journal of physical chemistry. C, 2018-01, Vol.122 (2), p.1091-1102

2018

Volltextzugriff (PDF)

Abstract 1178: Phase I clinical trial of Lenalidomide in combination with Sorafenib in patients with advanced cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1178-1178

2013

Volltextzugriff (PDF)

Abstract 1224: Discovery of novel BAF inhibitors for the treatment of transcription factor-driven cancers

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1224-1224

2021

Volltextzugriff (PDF)

Abstract 1265: Mechanisms underlying genomic integrity in breast cancer-derived dormant circulating tumor cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1265-1265

2017

Volltextzugriff (PDF)

Abstract 1279: Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1279-1279

2011

Volltextzugriff (PDF)

Abstract 1287: Profile-related evidence to determine individualized cancer therapy (PREDICT): Preliminary results of the Personalized Phase I Clinical Trials program at MD Anderson Cancer Center

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1287-1287

2011

Volltextzugriff (PDF)

Abstract 1530: Dissecting breast cancer dormant CTC phenotypes

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1530-1530

2016

Volltextzugriff (PDF)

Abstract 164: PIK3CA mutation, aspirin use and mortality in patients with metastatic colorectal cancer participating in early-phase clinical trials

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.164-164

2013

Volltextzugriff (PDF)

Abstract 1700: Metabolic adaptations confer immunotherapy resistance in melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1700-1700

2018

Volltextzugriff (PDF)

Abstract 1751: A phase I study of lenalidomide in combination with bevacizumab, sorafenib, temsirolimus, or 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in patients with advanced cancers

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1751-1751

2012

Volltextzugriff (PDF)

Abstract 2057: Cigarette smoke enhances pulmonary carcinogenesis via downregulation of has-miR-487b in respiratory epithelial cells

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2057-2057

2010

Volltextzugriff (PDF)

Abstract 2264: K-ras mutations in colorectal cancer may predict a pattern of organ-specific metastasis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2264-2264

2011

Volltextzugriff (PDF)

Abstract 2308: Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2308-2308

2023

Volltextzugriff (PDF)

Abstract 2407: Multiplex KRAS G12/G13 mutation testing of 16ng of unamplified cell-free DNA from plasma of patients with advanced cancers using Droplet Digital PCR

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2407-2407

2015

Volltextzugriff (PDF)

Abstract 2413: Rapid, automated BRAF mutation testing of cell-free DNA from plasma of patients with advanced cancers using the novel Idylla platform

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2413-2413

2015

Volltextzugriff (PDF)

Abstract 2414: Novel, ultra deep next-generation sequencing of plasma cell-free DNA from patients with advanced cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2414-2414

2015

Volltextzugriff (PDF)

Abstract 246: Phase 1 study: Ipilimumab (anti CTLA-4) in combination with Lenalidomide in patients with advanced cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.246-246

2015

Volltextzugriff (PDF)

Abstract 2499: Clinical and immunopathological effects following Image-guided intratumoral injection of activated, autologous dendritic cells in patients with advanced solid cancers

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2499-2499

2015

Volltextzugriff (PDF)

Abstract 2562: Affinity-enhanced T-cell receptor (TCR) for adoptive T-cell therapy targeting MAGE-A4

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2562-2562

2018

Volltextzugriff (PDF)

Abstract 2669: Early-phase trials in patients with advanced gallbladder cancer and cholangiocarcinoma: The MD Anderson Clinical Center for Targeted Therapy experience

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2669-2669

2012

Volltextzugriff (PDF)

Abstract 2687: Development of a new, highly sensitive assay for circulating tumor cell (CTC) detection based on the CellSearch® CTC Profile Kit enrichment and laser scanning cytometry analysis

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2687-2687

2010

Volltextzugriff (PDF)

1 – 25 von 1.696

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionRCN full-text journals@Ovid

Zeitschrift / SeriePlos One

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.249)
Mit Volltextzugriff
(1.580)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.012)
Technology
(498)
Computer Science
(471)
Life Sciences & Biomedicine
(466)
Humans
(366)
Computer Science, Theory & Methods
(334)
Computer Science, Information Systems
(258)
Computer Science, Software Engineering
(258)
Female
(191)
Oncology
(182)
Male
(179)
Middle Aged
(137)
Adult
(128)
Aged
(120)
Exact Sciences And Technology
(115)
Applied Sciences
(110)
Computer Science; Control Theory; Systems
(105)
Animals
(100)
Computer Science, Artificial Intelligence
(95)
Computer Science, Hardware & Architecture
(91)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

2D/3D cryo x-ray fluorescence imaging at the bionanoprobe at the advanced photon source

3D-VUPID: 3D Visual Urban Planning Integrated Data

901: Guidelines for dosimetric tracking using reference points in radiation oncology information systems

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma

Ability To Fine-Tune the Electronic Properties and Open-Circuit Voltage of Phenoxy-Boron Subphthalocyanines through Meta-Fluorination of the Axial Substituent

Abstract 1178: Phase I clinical trial of Lenalidomide in combination with Sorafenib in patients with advanced cancer

Abstract 1224: Discovery of novel BAF inhibitors for the treatment of transcription factor-driven cancers

Abstract 1265: Mechanisms underlying genomic integrity in breast cancer-derived dormant circulating tumor cells

Abstract 1279: Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors

Abstract 1287: Profile-related evidence to determine individualized cancer therapy (PREDICT): Preliminary results of the Personalized Phase I Clinical Trials program at MD Anderson Cancer Center

Abstract 1530: Dissecting breast cancer dormant CTC phenotypes

Abstract 164: PIK3CA mutation, aspirin use and mortality in patients with metastatic colorectal cancer participating in early-phase clinical trials

Abstract 1700: Metabolic adaptations confer immunotherapy resistance in melanoma

Abstract 1751: A phase I study of lenalidomide in combination with bevacizumab, sorafenib, temsirolimus, or 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in patients with advanced cancers

Abstract 2057: Cigarette smoke enhances pulmonary carcinogenesis via downregulation of has-miR-487b in respiratory epithelial cells

Abstract 2264: K-ras mutations in colorectal cancer may predict a pattern of organ-specific metastasis

Abstract 2308: Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC)

Abstract 2407: Multiplex KRAS G12/G13 mutation testing of 16ng of unamplified cell-free DNA from plasma of patients with advanced cancers using Droplet Digital PCR

Abstract 2413: Rapid, automated BRAF mutation testing of cell-free DNA from plasma of patients with advanced cancers using the novel Idylla platform

Abstract 2414: Novel, ultra deep next-generation sequencing of plasma cell-free DNA from patients with advanced cancers

Abstract 246: Phase 1 study: Ipilimumab (anti CTLA-4) in combination with Lenalidomide in patients with advanced cancers

Abstract 2499: Clinical and immunopathological effects following Image-guided intratumoral injection of activated, autologous dendritic cells in patients with advanced solid cancers

Abstract 2562: Affinity-enhanced T-cell receptor (TCR) for adoptive T-cell therapy targeting MAGE-A4

Abstract 2669: Early-phase trials in patients with advanced gallbladder cancer and cholangiocarcinoma: The MD Anderson Clinical Center for Targeted Therapy experience

Abstract 2687: Development of a new, highly sensitive assay for circulating tumor cell (CTC) detection based on the CellSearch® CTC Profile Kit enrichment and laser scanning cytometry analysis

Aktive Filter

Suchergebnisse filtern